Markets › United States › NAS › MESO

Mesoblast Ltd

NAS:MESOHealthcareNASDAQ:NBINASDAQ:NCX

$12.41+3.85%At closeAt close · Wed 21 Oct · ≈ AED 45.58 · Market cap $1.61B · Next earnings Thu 4 Mar

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	−1,049.8%	−522.6%	−632.2%	−595.9%	70.2%	84.1%	—	—
Operating margin	−1,463.2%	−789.1%	−923.7%	−1,425.7%	−363.1%	−42.6%	−363.1%	−320.4 pts
Net margin	−1,325.3%	−894.6%	−1,091.7%	−1,490.3%	−593.9%	−47.8%	−593.9%	−546.1 pts
EBITDA margin	−1,135.4%	−749.9%	−780.6%	−950.1%	−428.3%	−35.5%	—	—
Return on equity	−17.0%	−18.4%	−16.3%	−18.3%	−17.1%	−10.2%	−17.1%	−6.9 pts
Return on assets	−13.3%	−13.8%	−12.2%	−13.1%	−13.0%	−7.5%	−13.0%	−5.5 pts
Return on capital employed	−16.8%	−13.2%	−11.0%	−14.1%	−9.2%	−7.4%	—	—
Debt / equity	0.2×	0.2×	0.2×	0.2×	0.2×	0.2×	0.2×	−4.2%
Debt / assets	14.2%	16.1%	17.4%	17.8%	16.3%	16.5%	—	—
Interest coverage	−10.2×	−4.7×	−3.6×	−4.1×	−2.7×	−2.2×	—	—
Current ratio	1.6×	1.4×	1.9×	1.2×	2.0×	2.4×	2.0×	−18.2%
Quick ratio	1.6×	1.4×	1.9×	1.2×	1.8×	2.1×	—	—
Cash ratio	1.5×	1.2×	1.7×	0.9×	1.6×	1.3×	1.6×	+23.8%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.2×	—	—
Inventory turnover	−340.2×	—	—	—	0.2×	0.7×	—	—
Receivables turnover	1.6×	2.3×	1.1×	0.3×	1.2×	2.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—